Eagle Genomics, a Cambridge, UK-based TechBio platform business applying network science to biology, received an undisclosed amount in funding from Omron Ventures.
The current funding round is ongoing, and open for additional investment opportunities.
The company intends to use the funds to support the ongoing development of its platform as well as continued global expansion and increased client impact.
Led by CEO Anthony Finbow, Eagle Genomics leverages an AI-augmented knowledge discovery platform that empowers scientists to exploit multi-dimensional data to help companies conduct science-led innovation for next-generation products. It supports the entire innovation workflow – from hypothesis through insight to product claims – helping bring novel, safer and sustainable products to market, faster, across the Food and Nutrition, Beauty and Personal Care, AgBio and BioPharma industries.
Omron Ventures joined existing investors abrdn, Environmental Technologies Fund and consortium led by Granpool Innovative Investments. In October 2022, Eagle Genomics announced a USD $20m first close of its scale-up funding round. The round was led by abrdn plc, with continued participation from existing investors Environmental Technologies Fund, and a consortium of investors headed by Granpool Innovative Investments.
FinSMEs
16/01/2023